Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTPS9579A in uncontrolled asthma
NCT04092582Phase 2Completed
- Sponsor
- Genentech
- Start
- Oct 2019
- Primary completion
- May 2022
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of MTPS9579A in asthma, sponsored by Genentech. Started Oct 2019; status: completed.
02
Drugs
MTPS9579A
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04092582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04092582.